Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kay-Won Chang

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Texas Heart Institute Journal|December 15, 2015
Pericardial Effusion in Patients with End-Stage Renal DiseaseKay-Won Chang, Gabriel Marcelo Aisenberg
International Journal of Cardiology|June 10, 2017
Antithrombotic regimens in patients with atrial fibrillation and coronary artery disease after percutaneous coronary intervention: A focused reviewKay-Won Chang, Boris Arbit, Jonathan C Hsu
Expert Review of Cardiovascular Therapy|August 24, 2017
Using biomarkers to guide heart failure managementKay-Won Chang, Sutton Fox, Sean Mojaver, et al.
Current Heart Failure Reports|July 11, 2018
The Confounding Effects of Non-cardiac Pathologies on the Interpretation of Cardiac BiomarkersMarin Nishimura, Alison Brann, Kay-Won Chang, et al.
The American Journal of Medicine|August 21, 2017
Clinical Applications of Biomarkers in Atrial FibrillationKay-Won Chang, Jonathan C Hsu, Avinash Toomu, et al.
American Journal of Infection Control|November 13, 2018
Observation of stethoscope sanitation practices in an emergency department settingRajiv S Vasudevan, Sean Mojaver, Kay-Won Chang, et al.
The American Journal of Cardiology|November 12, 2013
Comparison of outcomes for patients ≥75 years of age treated with pre-hospital reduced-dose fibrinolysis followed by percutaneous coronary intervention versus percutaneous coronary intervention alone for treatment of ST-elevation myocardial infarctionAmirreza Solhpour, Kay-Won Chang, Prakash Balan, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 3, 2015
Ischemic time is a better predictor than door-to-balloon time for mortality and infarct size in ST-elevation myocardial infarctionAmirreza Solhpour, Kay-Won Chang, Salman A Arain, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 31, 2016
Comparison of 30-day mortality and myocardial scar indices for patients treated with prehospital reduced dose fibrinolytic followed by percutaneous coronary intervention versus percutaneous coronary intervention alone for treatment of ST-elevation myocardial infarctionAmirreza Solhpour, Kay-Won Chang, Salman A Arain, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|December 9, 2014
Preservation of native aortic valve flow and full hemodynamic support with the TORVAD using a computational model of the cardiovascular systemJeffrey R Gohean, Mitchell J George, Kay-Won Chang, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Texas Heart Institute Journal|December 15, 2015
Pericardial Effusion in Patients with End-Stage Renal DiseaseKay-Won Chang, Gabriel Marcelo Aisenberg
International Journal of Cardiology|June 10, 2017
Antithrombotic regimens in patients with atrial fibrillation and coronary artery disease after percutaneous coronary intervention: A focused reviewKay-Won Chang, Boris Arbit, Jonathan C Hsu
Expert Review of Cardiovascular Therapy|August 24, 2017
Using biomarkers to guide heart failure managementKay-Won Chang, Sutton Fox, Sean Mojaver, et al.
Current Heart Failure Reports|July 11, 2018
The Confounding Effects of Non-cardiac Pathologies on the Interpretation of Cardiac BiomarkersMarin Nishimura, Alison Brann, Kay-Won Chang, et al.
The American Journal of Medicine|August 21, 2017
Clinical Applications of Biomarkers in Atrial FibrillationKay-Won Chang, Jonathan C Hsu, Avinash Toomu, et al.
American Journal of Infection Control|November 13, 2018
Observation of stethoscope sanitation practices in an emergency department settingRajiv S Vasudevan, Sean Mojaver, Kay-Won Chang, et al.
The American Journal of Cardiology|November 12, 2013
Comparison of outcomes for patients ≥75 years of age treated with pre-hospital reduced-dose fibrinolysis followed by percutaneous coronary intervention versus percutaneous coronary intervention alone for treatment of ST-elevation myocardial infarctionAmirreza Solhpour, Kay-Won Chang, Prakash Balan, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 3, 2015
Ischemic time is a better predictor than door-to-balloon time for mortality and infarct size in ST-elevation myocardial infarctionAmirreza Solhpour, Kay-Won Chang, Salman A Arain, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 31, 2016
Comparison of 30-day mortality and myocardial scar indices for patients treated with prehospital reduced dose fibrinolytic followed by percutaneous coronary intervention versus percutaneous coronary intervention alone for treatment of ST-elevation myocardial infarctionAmirreza Solhpour, Kay-Won Chang, Salman A Arain, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|December 9, 2014
Preservation of native aortic valve flow and full hemodynamic support with the TORVAD using a computational model of the cardiovascular systemJeffrey R Gohean, Mitchell J George, Kay-Won Chang, et al.
Pageof 2